Cash Flow Statement
Growth Metrics

Ani Pharmaceuticals (ANIP) Receivables - Other (2018 - 2022)

Ani Pharmaceuticals' Receivables - Other history spans 5 years, with the latest figure at $5.0 million for Q4 2022.

  • On a quarterly basis, Receivables - Other changed N/A to $5.0 million in Q4 2022 year-over-year; TTM through Dec 2022 was $5.0 million, a N/A change, with the full-year FY2022 number at $5.0 million, changed N/A from a year prior.
  • Receivables - Other hit $5.0 million in Q4 2022 for Ani Pharmaceuticals, up from $100000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for ANIP hit a ceiling of $5.0 million in Q4 2022 and a floor of $14000.0 in Q3 2018.
  • Historically, Receivables - Other has averaged $581400.0 across 4 years, with a median of $100000.0 in 2018.
  • The widest YoY moves for Receivables - Other: up 614.29% in 2019, down 0.0% in 2019.
  • Tracing ANIP's Receivables - Other over 4 years: stood at $100000.0 in 2018, then changed by 0.0% to $100000.0 in 2019, then changed by 0.0% to $100000.0 in 2020, then soared by 4900.0% to $5.0 million in 2022.
  • Business Quant data shows Receivables - Other for ANIP at $5.0 million in Q4 2022, $100000.0 in Q3 2020, and $100000.0 in Q2 2020.